Save Time, Improve Evidence Generation with Linked Data

 

In today's highly fluid market environment, life science companies need information that's highly accurate and timely to meet the needs of both patients and their product portfolios. Traditionally, acquiring all the necessary data often required companies to design and conduct large primary research studies that were often expensive and time consuming or conduct multiple studies using different secondary data sources.

Kantar’s new Claritis™ solution provides you with the opportunity to save valuable time and resources by analyzing Patient Reported Outcomes (PROs) and clinical data together, thus creating more timely and efficient evidence generation. That's because, for the first time ever, we are now able to link PRO and clinical data.

By utilizing Claritis linked data, you don’t have to wait for the information you need, as you're generating patient-level evidence that's available immediately – uncovering previously unseen patient evidence. The result is an assemblage of key learnings about patients living with a disease and applying these unique insights to get to the very heart of how patients and healthcare consumers experience and interact with the healthcare system.

A BREAKTHROUGH APPROACH IN REAL WORLD DATA ANALYTICS

Claritis successfully links PRO and clinical data, a major advancement in real world research. Claritis supports a host of evidence generation scenarios, including: providing payer agencies with the required evidence to support reimbursement decisions, supporting regulatory bodies that require evidence of real-world safety and effectiveness, and generating critical information that's used by other healthcare stakeholders, including healthcare professionals, patients and caregivers.

CLARITIS™: THE LINK BETWEEN PRO DATA
AND EVIDENCE

SAVE TIME

Generates data and evidence immediately

A MAJOR INDUSTRY ADVANCEMENT

Linking our proprietary PACER data and Clinical data

HARNESS PACER PLATFORM

PACER is Kantar's proprietary global survey of the general population

CLINICAL DATA

Kantar has access to a wide variety of clinical data

DATA CLARITY LIKE NEVER BEFORE

To give a complete picture of the patient

Kantar's linked data

Kantar's Claritis linking process maintains the patient confidentiality that's required by HIPAA regulations. Our Claritis linked data offers:

  • A HIPAA-certified approach for linking de-identified clinical data with de-identified survey data.
  • Highly accurate probabilistic matching.
  • Linking software validated at error rates less than industry standards
Brand Plus Framework Analytics

LEARN HOW CLARITIS CAN GENERATE EVIDENCE FOR REAL WORLD RESEARCH

Download the brochure.

Please review Kantar terms & conditions and privacy policy.